Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections

Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections

The type I interferon (IFN-I) response is a critical component of the immune defense against various viral pathogens, triggering the expression of hundreds of interferon-stimulated genes (ISGs). These ISGs encode proteins with diverse antiviral functions, targeting various stages of viral replicatio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chien-Hsin Huang, Maudry Laurent-Rolle, Tyler L. Grove, Jack Chun-Chieh Hsu
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Viruses
Subjects:	Biomarker type I Interferon ISGs ddhC MxA ISG15
Online Access:	https://www.mdpi.com/1999-4915/17/1/132
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficiency of interferon stimulated gene 15 expression in peripheral blood for early pregnancy prediction in Awassi ewes
by: Eman H. Lazim, et al.
Published: (2025-01-01)

ISG15 promotes M5-induced hacat cell proliferation through Wnt signaling in psoriasis
by: Sun Xianqi, et al.
Published: (2025-01-01)

Proteomics and transcriptomics combined reveal specific immunological markers in autoimmune thyroid disease
by: Xia Chen, et al.
Published: (2025-01-01)

Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
by: R. M. Hayes, et al.
Published: (2024-09-01)

Diagnostic ability of myxovirus resistance-A in pediatric cases of viral-acute respiratory tract infections with vitamin A and zinc deficiencies
by: Dian Kesumapramudya Nurputra, et al.
Published: (2025-03-01)

Change of Occupational Health and Safety (OHS) University Students' Perceptions on OHS in Parallel to Vocational Training: The Comparative Analysis
by: Derya Çevik Taşdemir, et al.
Published: (2023-09-01)

The concerted actions of microRNA-29a and interferon-β modulate complete Freund's adjuvant-induced inflammatory pain by regulating the expression of type 1 interferon receptor, interferon-stimulated gene 15, and p-extracellular signal-regulated kinase
by: Chien-Cheng Liu, et al.
Published: (2025-03-01)

A practical guide for choosing an optimal spatial transcriptomics technology from seven major commercially available options
by: Hyun Ju Lim, et al.
Published: (2025-01-01)

Arthroscopic-assisted reduction for Developmental Hip Dysplasia (DDH) through the sub-adductor and anterolateral portals; A 24-month follow-up prospective descriptive study
by: Amr Samir Rashwan, et al.
Published: (2025-01-01)

The effect of interferon alpha administration on cytokine levels in sheep
by: Devran Coşkun, et al.
Published: (2020-12-01)

Heightened expression of type I interferon signaling genes in CD4+ T cells from acutely HIV-1–infected women is associated with lower viral loads
by: Elina El-Badry, et al.
Published: (2025-01-01)

Preliminary Diagnosis and Characterization of a Spontaneous Immature Testicular Teratoma in an Interferon Receptor-Deficient Mouse Model
by: ZHAO He, et al.
Published: (2024-12-01)

Diagnostic value of interferon-γ release assay in patients with COPD complicated with pulmonary tuberculosis
by: Yanxiao Rong, et al.
Published: (2025-01-01)

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
by: Kira A Cozzolino, et al.
Published: (2025-02-01)

Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
by: Leslie Pérez Ruiz, et al.
Published: (2007-12-01)

Divergent Effects of <i>Circoviridae</i> Capsid Proteins on Type I Interferon Signaling
by: Anon H. Kosaka, et al.
Published: (2025-01-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01)

Infectious bursal disease virus affecting interferon regulatory factor 7 signaling through VP3 protein to facilitate viral replication
by: Zhiyuan Wang, et al.
Published: (2025-01-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Development of a family-centred core outcome set for infants with developmental dysplasia of the hip treated with a brace
by: Joanna Craven, et al.
Published: (2025-01-01)

Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
by: Jie Zhao, et al.
Published: (2025-02-01)

ZBP1 senses Brucella abortus DNA triggering type I interferon signaling pathway and unfolded protein response activation
by: Marco Túlio R. Gomes, et al.
Published: (2025-01-01)

Regulation of viral replication by host restriction factors
by: Ying Lin, et al.
Published: (2025-01-01)

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
by: Sandra Schwarzlose-Schwarck, et al.
Published: (2025-02-01)

Species- and strain-specific microbial modulation of interferon, innate immunity, and epithelial barrier in 2D air–liquid interface respiratory epithelial cultures
by: Mian Horvath, et al.
Published: (2025-01-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

An artificial transcription factor that activates potent interferon-γ expression in human Jurkat T Cells
by: Ashley King, et al.
Published: (2025-01-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Regulation of interferon alpha production by the MAGUK-family protein CASK under H5N1 infection
by: Jing-Ying Huang, et al.
Published: (2025-01-01)

Mapping integral cell-type-specific interferon-induced gene regulatory networks (GRNs) involved in systemic lupus erythematosus using systems and computational analysis
by: Blessy Kiruba, et al.
Published: (2025-01-01)

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis
by: Loïs Bolko, et al.
Published: (2025-02-01)

NRF2 Antioxidant Response and Interferon‐Stimulated Genes Are Differentially Expressed in SARS‐CoV‐2‐Positive Young Subjects
by: Walter Toscanelli, et al.
Published: (2025-01-01)

A cGAMP‐Containing Hydrogel for Prolonged SARS‐CoV‐2 Receptor‐Binding Domain Subunit Vaccine Exposure Induces a Broad and Potent Humoral Response
by: Volker Böhnert, et al.
Published: (2025-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01)

Morphological and bone defect mapping analysis of true acetabulum in Crowe type IV hip dysplasia
by: Yuhui Yang, et al.
Published: (2024-12-01)

Efficacy and safety of interferon-alpha 1b injection into the intervertebral foramen with ultrasonic guidance in patients with postherpetic neuralgia: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial
by: Hui-Min Hu, et al.
Published: (2025-01-01)

The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
by: Na Chen, et al.
Published: (2025-01-01)

Evolución clínica de pacientes con esclerosis múltiple remitente- recurrente tratados con interferón beta-1a
by: Lazaro Aurelio Vazquez-Gomez, et al.
Published: (2022-09-01)